The price of Zai Lab Limited ADR (NASDAQ: ZLAB) closed at $17.21 in the last session, down -5.80% from day before closing price of $18.27. In other words, the price has decreased by -$1.06 from its previous closing price. On the day, 921175 shares were traded.
Ratios:
We take a closer look at ZLAB’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 4.41 and its Current Ratio is at 4.63. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Morgan Stanley on December 14, 2023, initiated with a Overweight rating and assigned the stock a target price of $47.50.
On August 10, 2023, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $70.
On January 21, 2022, Macquarie started tracking the stock assigning a Outperform rating and target price of $64.Macquarie initiated its Outperform rating on January 21, 2022, with a $64 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 15 ’24 when Edmondson Frazor Titus III sold 10,000 shares for $18.71 per share. The transaction valued at 187,127 led to the insider holds 20,005 shares of the business.
Amado Rafael sold 2,544 shares of ZLAB for $47,980 on Mar 15 ’24. The insider now owns 20,093 shares after completing the transaction at $18.86 per share. On Mar 01 ’24, another insider, Smiley Joshua L, who serves as the insider of the company, bought 3,000 shares for $20.83 each. As a result, the insider paid 62,490 and bolstered with 23,527 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ZLAB now has a Market Capitalization of 1.76B and an Enterprise Value of 964.58M. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.37 while its Price-to-Book (P/B) ratio in mrq is 2.10. Its current Enterprise Value per Revenue stands at 3.62 whereas that against EBITDA is -2.64.
Stock Price History:
Over the past 52 weeks, ZLAB has reached a high of $40.42, while it has fallen to a 52-week low of $17.68. The 50-Day Moving Average of the stock is 21.09, while the 200-Day Moving Average is calculated to be 25.30.
Shares Statistics:
According to the various share statistics, ZLAB traded on average about 658.80K shares per day over the past 3-months and 572.09k shares per day over the past 10 days. A total of 98.72M shares are outstanding, with a floating share count of 98.31M. Insiders hold about 0.41% of the company’s shares, while institutions hold 42.47% stake in the company. Shares short for ZLAB as of Feb 29, 2024 were 4.06M with a Short Ratio of 6.17, compared to 4.9M on Jan 31, 2024.
Earnings Estimates
The company has 5 analysts who recommend its stock at the moment. On average, analysts expect EPS of -$0.9 for the current quarter, with a high estimate of -$0.75 and a low estimate of -$1.04, while EPS last year was -$0.51. The consensus estimate for the next quarter is -$0.85, with high estimates of -$0.75 and low estimates of -$0.91.
Analysts are recommending an EPS of between $5.6 and -$3.53 for the fiscal current year, implying an average EPS of -$2.24. EPS for the following year is -$1.26, with 8 analysts recommending between $3.4 and -$2.63.
Revenue Estimates
According to 5 analysts, the current quarter’s revenue is expected to be $74.19M. It ranges from a high estimate of $77.66M to a low estimate of $67.9M. As of the current estimate, Zai Lab Limited ADR’s year-ago sales were $64.97M, an estimated increase of 14.20% from the year-ago figure. For the next quarter, 5 analysts are estimating revenue of $86.17M, an increase of 22.00% over than the figure of $14.20% in the same quarter last year. There is a high estimate of $87.2M for the next quarter, whereas the lowest estimate is $84.59M.
A total of 9 analysts have provided revenue estimates for ZLAB’s current fiscal year. The highest revenue estimate was $398M, while the lowest revenue estimate was $365.7M, resulting in an average revenue estimate of $381.69M. In the same quarter a year ago, actual revenue was $266.72M, up 43.10% from the average estimate. Based on 8 analysts’ estimates, the company’s revenue will be $590.86M in the next fiscal year. The high estimate is $647.33M and the low estimate is $533.5M. The average revenue growth estimate for next year is up 54.80% from the average revenue estimate for this year.
